Novo Nordisk Investigational Site — Topeka, Kansas

Novo Nordisk Investigational Site is a clinical research site located in Topeka, Kansas, United States 66606.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Novo Nordisk Investigational Site has participated in 35 clinical trials.

Therapeutic areas: Diabetes, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1.

Sponsors: Novo Nordisk A/S.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Novo Nordisk Investigational Site?

Novo Nordisk Investigational Site has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Novo Nordisk Investigational Site conducted?

Novo Nordisk Investigational Site has 35 clinical trials on record. Their work covers Diabetes, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1.

Is Novo Nordisk Investigational Site accredited by Crixeo Health?

Yes — Novo Nordisk Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Novo Nordisk Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.